ProSomnus(OSA) - 2023 Q4 - Annual Results

Exhibit 99.1 ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results PLEASANTON, Calif., (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy™ for the treatment of Obstructive Sleep Apnea (OSA), today announced financial results for the fourth quarter and year ended December 31, 2023. Recent Business Highlights · Generated record revenues of $7.8 million for the fourth quarter and $27.7 million for the fiscal year 2023, a 35% increase compared to $5.8 millio ...